Verification test on pancreatic cancer diagnosis by pancreatic juice cytology using synthetic secreti
Phase 2
Recruiting
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000031492
- Lead Sponsor
- Division of Gastroenterology and Nephrology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University
- Brief Summary
under investigation
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 196
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with hypersensitivity to secretin or other ingredients (excipients: glycine hydrochloride, glycine, and polypeline). 2) Patients within 2 weeks after remission from acute pancreatitis or acute exacerbations of chronic pancreatitis. 3) A pregnant or lactating woman. 4) Patients who received other research drugs or investigational drugs within 3 months prior to the start
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method